Document:

exv10w12

[*] Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

EXHIBIT 10.12

OEM PURCHASING AGREEMENT

     This Agreement (the “Agreement”) is entered into as of March 15, 2006 (the “Effective Date”),
by and between ZONARE MEDICAL SYSTEMS, INC., a Delaware corporation with principal offices at 1061
Terra Bella Avenue, Mountain View, California 94043, U.S.A. (“ZONARE”) and Fuji Photo Film Co.
Ltd., 26-30, Nishazabu 2-Chome Minato-Ku, Tokyo 106-8620, Japan (“Fuji”).

Witnesseth

     WHEREAS, Fuji wishes to purchase certain ultrasound medical image diagnostic equipment
manufactured by ZONARE and resell it under its own brand in the market of Japan; and

     WHEREAS, ZONARE is willing to sell such products to Fuji;

     NOW; THEREFORE, in consideration of the premises and the mutual covenants herein contained,
the parties agree as follows:

     1. Definitions

          (a) “Products” shall mean those products listed in Exhibit A attached hereto.
Products may be changed on, abandoned from or added to the list by mutual agreement of the parties
hereto.

          (b) “Territory” shall mean that geographic area identified in Exhibit A attached
hereto.

     2. Supply and Purchase

          (a) ZONARE hereby agrees to sell to Fuji and Fuji hereby agrees to purchase the Products in
accordance with the terms and conditions hereinafter set forth.

          (b) As long as Fuji is performing in compliance with this Agreement, ZONARE shall not sell the
Products to any third party for resale or use in the Territory.

          (c) Fuji warrants that it is legally authorized to import the Products into the Territory and
to distribute them therein, and that it will exercise its best efforts to maintain these
authorizations during the term of this Agreement.

          (d) Fuji shall pursue aggressive sales policies and procedures to realize the maximum sales
potential for the Products in the Territory. Subject to applicable laws or regulations, Fuji shall
promote and sell the Products to customers only for use or consumption within the Territory, and
Fuji agrees not to solicit orders outside the Territory without the prior written approval of
ZONARE.

 

 

          (e) The relationship of ZONARE and Fuji established by this Agreement is that of independent
contractors, and nothing contained in this Agreement shall be construed to (i) give either party
the power to direct or control the day-to-day activities of the other, (ii) constitute the parties
as partners, joint venturers, co-owners or otherwise as participants in a joint or common
undertaking, or (iii) allow either party to create or assume any obligation on behalf of the other
party for any purpose whatsoever. All financial obligations associated with Fuji’s business are
the sole responsibility of Fuji. All sales and other agreements between Fuji and its customers are
Fuji’s exclusive responsibility and shall have no effect on Fuji’s obligations under this
Agreement.

          (f) Each party represents and warrants to the other party that (i) such party is a corporation
duly organized, validly existing and in good standing under the laws of its incorporating
jurisdiction, and has all requisite corporate power and authority to enter into this Agreement;
(ii) the party is duly authorized by all requisite action to execute, deliver and perform this
Agreement and to consummate the transactions contemplated hereby in accordance with their terms,
and that the same do not conflict with or cause a default with respect to its obligations under any
other agreement; and (iii) such party has duly executed and delivered this Agreement.

     3. Terms Of Purchase Of Products By Fuji

          (a) Terms and Conditions. All purchases of Products by Fuji from ZONARE during the
term of this Agreement shall be subject to the terms and conditions of this Agreement.

          (b) Prices. All prices are [*]. The purchase price to Fuji for each of the Products
(“Purchase Price”) shall be as set forth in Exhibit B attached hereto. ZONARE and Fuji may
revise the prices in Exhibit B by mutual agreement. Such revisions shall apply to all
orders received after the effective date of revision. Price increases shall not affect unfulfilled
purchase orders accepted by ZONARE before the effective date of the price increase. Price
decreases shall apply to pending purchase orders that are not yet accepted by ZONARE before the
effective date of the decrease.

          (c) Order and Acceptance. All orders for Products submitted by Fuji shall be
initiated by written purchase order delivered in person or by first class mail, facsimile or
electronic submission to ZONARE during the term of this Agreement. No order shall be binding upon
ZONARE until accepted by ZONARE in writing. ZONARE shall use its reasonable best efforts to notify
Fuji of the acceptance or rejection of an order and of the assigned delivery date for accepted
orders within [*] after receipt of the purchase order. ZONARE may accept a purchase order by
electronic transmission, in writing, or other methods of express acceptance. ZONARE shall have no
liability to Fuji with respect to purchase orders that are not accepted. ZONARE shall use
commercially reasonable efforts to deliver Products within [*] after acceptance of Fuji’s purchase
orders.

          (d) Terms of Purchase Orders. Fuji’s purchase orders submitted to ZONARE from time to
time with respect to Products to be purchased hereunder shall be governed by the terms of this
Agreement, and nothing contained in any such purchase order shall in any way modify such terms of
purchase or add or delete any additional terms or conditions. All sales of the Products to Fuji
under this Agreement shall be at ZONARE’s then-current prices, in [*], as reflected on Exhibit
B. All such purchase orders shall include the purchase order number; billing address; name,
list number, quantity of Products being ordered, requested delivery date, detailed shipping
instructions, if any. In the event of a conflict between the terms of this Agreement and the terms
of any purchase order form or other document submitted by Fuji to ZONARE in connection with any

2

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

 order for
Products, this Agreement shall control unless the parties specifically otherwise agree in writing.

          (e) Change Orders. Fuji may utilize written change orders without penalty for orders
that have not yet been accepted by ZONARE. Any other change orders shall be subject to acceptance
by ZONARE, at its sole discretion.

          (f) Payment. Full payment of Fuji’s Purchase Price for the Products shall be made by
Fuji to ZONARE per Fuji’s standard international payment schedule but in no case later than , net
[*]. All exchange, interest, banking, collection, and other charges shall be at [*]. Any invoiced
amount not paid when due shall be subject to a service charge of [*] or the highest rate allowed by
law, whichever is lower.

          (g) Shipping. All Products delivered pursuant to the terms of this Agreement shall be
suitably packed for air freight shipment in ZONARE’s standard shipping cartons, marked for shipment
at Fuji’s address set forth above or as set forth on any applicable purchase order, and shall be
delivered to Fuji or its carrier agent [*] as designated by Fuji, at which time title to such
Products and risk of loss shall pass to Fuji. Unless otherwise instructed in writing by Fuji,
ZONARE shall select the carrier. All freight, insurance, and other shipping expenses and duties,
as well as any special packing expense, incurred after the delivery to Fuji or its carrier agent
shall be paid by [*].

          (h) Non-Conforming and Undelivered Goods. If any of Products delivered by ZONARE to
Fuji contains any non-conforming Product or contains fewer than the number of units of Products
ordered by Fuji, then Fuji shall notify ZONARE by facsimile or any other mean within [*] following
the delivery date, specifying the non-conformity or non-delivery in question. If Fuji fails to
provide ZONARE on a timely basis with any notice required by this Section 3(h) with respect
to any shipment of Products ordered by Fuji, then Fuji shall be deemed to have acknowledged the
timely delivery and conformity of all Products covered by that order, subject to Section 5.

     4. Training And Service

          (a) Services by Fuji. Fuji or Fuji’s designee will serve as the primary point of
contact for the delivery of after-sale services for the Products in the Territory. Fuji, or Fuji’s
designee, shall [*] with respect to the Products sold and provide [*]. The services shall be
performed only by specially and properly trained personnel of Fuji or Fuji’s designee and shall be
prompt and of the highest quality. Fuji or Fuji’s designee shall maintain properly equipped sales
and [*] departments as required and shall keep on hand, at all times, Products sufficient to
meet the needs of the Territory.

          (b) Training by ZONARE. ZONARE shall provide sales and technical training to the
personnel of Fuji and Fuji’s designee prior to initial Product shipment. The detail of such
training shall be discussed and agreed upon by the parties.

          (c) ZONARE Warranty Services Notwithstanding the foregoing provisions,
ZONARE shall, at the request of Fuji or Fuji’s designee, provide after-sale services for the
Products in the Territory according to the terms and conditions to be agreed upon between the
respective

3

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

parties per separate agreement. Such agreement shall be in place prior to any Product
shipments under this Agreement. Such after-sale services shall include, without limitation, replacement
parts, technical phone support, and software upgrades during the warranty term, as defined in
Section 5.

     5. Warranty

          (a) Limited Warranty. ZONARE warrants that the Products shall be free from defects in
material and workmanship [*] from the date of shipment of the Products from ZONARE’s or ZONARE’s
United States contractor’s manufacturing facility. During the warranty period, ZONARE will provide
spare parts and technical assistance phone support during regular business hours (PST) excluding
holidays. Further, ZONARE warrants the software, when used as permitted under this Agreement, will
operate as described in the product documentation for [*] from the date of shipment of the Products
from ZONARE’s or ZONARE’s United States contractor’s manufacturing facility. Software upgrades,
when and if available, will be provided at [*] during the warranty period. Software upgrades
consist of changes, bug fixes, improvements, or enhancements that enable the software to perform in
accordance with the product specifications as defined at the time of original equipment purchase.
New hardware, if required to run the software upgrade, will be made available at [*]. For spare
parts, add-ons, hardware upgrade packages, factory-rebuilt subassemblies (not under original
equipment warranty), the warranty is [*] from the date of shipment of the Products from ZONARE’s or
ZONARE’s United States contractor’s manufacturing facility unless otherwise agreed in writing by
ZONARE. All warranties are conditioned upon ZONARE’s receipt of notice of any defect prior to the
end of the applicable warranty period. The sole and exclusive remedy of Fuji for ZONARE’s breach
of the foregoing warranty shall be, in Fuji’s sole option, the replacement of a confirmed defective
Product or the refund of the purchase price paid by Fuji for such defective Product. This warranty
is contingent upon proper use of Products in the application for which they were intended as
indicated in the instructions for use therefor, and the foregoing warranty shall not apply to
Products that were modified, or otherwise altered or changed or used in conjunction with other
products, materials or substances, without ZONARE’s approval or that were subjected by the customer
to unusual physical, electrical or environment stress. Fuji shall pass on to its customers the
foregoing standard limited warranty and, except as required by law, Fuji shall not pass on to its
customers a warranty or limitation of liability which is more protective of such customers than the
warranty (including the limited remedy and exclusions) set forth in this Section 5 and the
limitation of liability set forth in Section 9.

          (b) No Other Warranty. EXCEPT FOR THE LIMITED WARRANTY PROVIDED IN THIS SECTION
5, ZONARE MAKES NO OTHER WARRANTIES OR CONDITIONS, EXPRESS OR IMPLIED, BY STATUTE OR OTHERWISE,
REGARDING THE PRODUCTS, AND ZONARE SPECIFICALLY DISCLAIMS THE IMPLIED WARRANTIES OF TITLE, FITNESS
FOR A PARTICULAR PURPOSE, MERCHANTABILITY, SATISFACTORY QUALITY AND THOSE ARISING OUT OF COURSE OF
DEALINGS OR USAGE IN TRADE. ZONARE NEITHER ASSUMES NOR AUTHORIZES ANY OTHER PERSON TO ASSUME ANY
OTHER LIABILITIES ARISING OUT OF OR IN CONNECTION WITH THE SALE OR USE OF ANY PRODUCT.
NOTWITHSTANDING THE FOREGOING, ZONARE DOES NOT EXCLUDE LIABILITY TO THE EXTENT THAT SUCH LIABILITY
MAY NOT BE EXCLUDED OR LIMITED BY LAW.

	6.	 	Additional Obligations Of Fuji

4

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

          (a) Minimum Purchase Commitment. Fuji and ZONARE have mutually agreed on the annual
quantity of Products to be purchased by Fuji from ZONARE as set forth in Exhibit C
(“Minimum Purchase Commitment”). A Product must be scheduled for shipment no later than [*] in accordance with ZONARE’s standard lead time
requirements to be counted toward the Minimum Purchase Requirement for such calendar year. If Fuji
fails to meet the Minimum Purchase Commitments in any given period, ZONARE may in its sole
discretion [*] and [*]. Fuji shall be released from the Minimum Purchase Commitment hereunder, to
the extent that Fuji’s non-fulfillment of the Minimum Purchase Commitment should be attributed to
ZONARE’s material non-performance of its obligations or material breach of any provision hereunder
or ZONARE’s failure to supply volume of the Products sufficient for Fuji to fulfill the Minimum
Purchase Commitment.

          (b) Forecasts. Within the [*] of every [*], Fuji shall provide ZONARE with a [*]
 forecast (“Forecast”) showing prospective orders by Product model. The Forecast shall not
be binding and shall be for planning purposes only.

          (c) Promotion of the Products. Fuji shall, [*], use its commercially reasonable
efforts to promote the sale of the Products within the Territory; provided, that such sales shall
be made for use only by qualified individuals as appropriate in the Territory, in compliance with
local laws and regulations and good commercial practices and for uses and applications intended for
the Products. Such promotion shall include but not be limited to preparing the promotional
material in appropriate languages for the Territory, advertising the Products in trade publications
within the Territory, participating in appropriate trade shows, and directly soliciting orders from
customers for the Products.

          (d) Representations. Fuji shall not make any false or misleading representations to
customers or others regarding ZONARE or the Products. Fuji shall not make any representations,
warranties or guarantees with respect to the specifications, features or capabilities of the
Products that are not consistent with ZONARE’s documentation accompanying the Products or ZONARE’s
literature describing the Products, including the limited warranty and disclaimers set forth
hereunder.

          (e) Fuji shall:

(i) maintain adequate contact with existing and potential customers within the Territory on a
regular basis, consistent with good business practice;

(ii) assist ZONARE in assessing customer requirements for the Products, including modifications and
improvements thereto, in terms of quality, design, functional capability, and other features; and

(iii) on the Effective Date and thereafter at the beginning of each calendar year, provide
ZONARE with a report containing information concerning current market conditions for the Products,
including information concerning introductions, promotional activities and sales levels of products
competitive with the Products and additional market research information, as reasonably requested
by ZONARE, regarding competition and changes in the market within the Territory, including without
limitation identification of competing products, market prices and market trends.

5

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

          (f) Customer Complaints. Fuji shall report to ZONARE material customer complaints
concerning the Products and serious or adverse reaction associated with the use of the
Products, or if Fuji shall otherwise become aware of material adverse experience with any of the
Products. Fuji shall cooperate fully with ZONARE in the resolution of such complaints, and shall
take such action to resolve such complaints as may be reasonably requested by ZONARE.

          (g) Import and Export Requirements. [*] shall, [*], pay all import and export
licenses and permits, pay customs charges and duty fees, and take all other actions required to
accomplish the export and import of the Products purchased by Fuji. Fuji understands that ZONARE
is subject to regulation by agencies of various governments, including the U.S. Department of
Commerce, which prohibit export or diversion of certain technical products to certain countries.
Fuji warrants that it will comply in all respects with the export and re-export restrictions set
forth in any required export license for every Product shipped to Fuji.

          (h) Government Regulations.

(i) Fuji agrees that it will secure any and all required approvals by any government other than the
United States of America and all required product and public health registrations for the
implementation, execution and performance of this Agreement, and ZONARE shall use best efforts to
assist Fuji to secure such approvals, as requested by Fuji. In particular, and without limitation
of the foregoing, Fuji shall exercise due diligence to promptly obtain and maintain government
approvals to import, register and market the Products in each jurisdiction in the Territory and to
diligently secure and maintain, as may be required from time to time, government importing,
registration and marketing approvals, import and export licenses, customs clearances and currency
authorizations and any permits necessary in each jurisdiction in the Territory. Fuji shall keep
ZONARE generally informed of the regulatory requirements in each jurisdiction in the Territory and
shall submit to the government health authorities in each jurisdiction in the Territory where the
sale of the Products is planned a complete application for registration and marketing plan, as
required. Fuji will bear all expenses for obtaining any such government approvals and product
registrations. Fuji shall obtain all necessary documents or licenses and shall comply with all
applicable laws, including, if required, registration of this Agreement. If for reasons outside of
its control Fuji is unable, within a reasonable time, not to exceed [*] after the Effective Date,
to obtain all necessary documents or licenses or to comply with all applicable laws in order to
perform this Agreement, then either party may terminate this Agreement upon giving [*] written
notice to the other party or may amend Exhibit A by deleting any product for which Fuji has
been unable to obtain the necessary government approvals. In such case, Fuji shall be released from
Minimum Purchase Commitment without any liability to ZONARE.

(ii) Fuji agrees that it shall not allow the Products supplied to it by ZONARE, any proprietary
data of ZONARE, or any direct product of such data, to be knowingly made available, either directly
or indirectly, or in any way to be knowingly given, transferred, sold or re-exported to any country
in violation of its laws and export control regulations or applicable laws of any country (or the
European Union). United States laws and export control regulations governing the exportability of
technical data and Products to nations are subject to change. If any country included within the
Territory shall, at the time of execution of this Agreement, be placed in an excluded category by
the United States government for the receipt of either technical data or the manufacture or sale of
products of the type supplied by ZONARE, Fuji agrees that it shall take all actions necessary to
cease business activity in Products in the excluded country. Fuji shall comply with all laws,
statutes, decrees, regulations and policies which have the effect of law in the Territory,
including but not limited to anti-bribery laws, and which apply to its activities under this
Agreement.

6

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

          (i) Compliance with US Laws. Fuji acknowledges and expressly agrees that certain laws
of the US, including, but not limited to, the Export Control Regulations, the Food and Drug Act and
the Foreign Corrupt Practices Act, may result in the imposition of sanctions on ZONARE or its
affiliates in the event that, directly or indirectly, (i) any Product is exported to various
countries, such as Cuba, Libya and North Korea, or any country embargoed by executive order, or
(ii) any Product is delivered to a customer that does not have authorization to use such Product
under the provisions of the Food and Drug Act and the regulations promulgated thereunder. Fuji
expressly agrees, therefore, that in performing its obligations under this Agreement it shall
comply at all times with such laws or regulations of the US, and shall furnish to ZONARE, by
affidavit or other reasonable means from time to time at ZONARE’s reasonable request, and to
ZONARE’s reasonable satisfaction, assurances that Fuji’s activities under this Agreement are proper
and lawful under the laws and regulations in the Territory. Fuji further agrees that no person
employed by it shall be an official of any government agency or a corporation owned by a
governmental unit within the Territory and that no proceeds from the sale of the Products in the
Territory shall accrue for the benefit of any such official.

          (j) Traceability Programs. Fuji agrees to maintain records to ensure the traceability
of the Products in accordance with applicable regulatory requirements, if any, and to provide
ZONARE or its authorized agents or representatives with reasonable access to such records. In
particular, and without limiting the generality of the foregoing, Fuji agrees to maintain a [*],
the [*]. Such records shall be kept for [*] years from the date of purchase.

          (k) Product Recalls. In the event that ZONARE deems it necessary to recall any
Product because such Product fails to comply with the warranties set forth in this Agreement, or if
any governmental authority shall request recall of any Product for any reason, Fuji shall promptly
effect such recall in accordance with its standard procedures then in effect. Fuji shall keep
ZONARE fully informed as to the status of such recall. Fuji shall initiate no communications
regarding any such recall with the news media, customers, governmental or regulatory authorities,
except if and to the extent required by applicable law, without the prior approval of ZONARE, which
approval will not be unreasonably withheld or delayed; provided, that Fuji shall notify all
affected customers within [*] of ZONARE’s request (unless a shorter period is required under
applicable laws or regulations), using materials and documentation prepared and approved by ZONARE,
and shall promptly provide ZONARE with a written status report of all units subject to the recall.
All costs and expenses associated with implementation of a recall shall be borne by ZONARE unless
the recall results primarily from fault attributable to Fuji; provided, that each party will
provide, at its expense, any assistance reasonably requested by the other party in connection with
the implementation of any recall pursuant to this Section 6(k).

          (l) Standard of Conduct. Each party agrees to use good judgment, high ethical
standards and honesty in its dealings with the other party, customers, end users, employees and
government officials, recognizing that even the appearance of unethical actions is not acceptable.

          (m) ISO Compliance. In the event the Territory includes any country adopting the
International Standards Organization 13485 (96) standards (or any successor thereto), Fuji shall
be in compliance with the standards applicable to Fuji’s activities under this Agreement at the
date the standards become effective, and shall furnish proof to ZONARE that Fuji is in compliance.
Fuji’s failure to comply with the provisions of this section shall give ZONARE the right to sell
and service the Products in the Territory directly or through a third party, and the right to
terminate this Agreement upon notice to Fuji.

7

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

     7. Additional Obligations Of ZONARE

          (a) Materials. ZONARE shall, at its expense, promptly provide Fuji with marketing and
technical information concerning the Products as well as reasonable quantities of brochures,
instructional material, advertising literature and other Product data, with all such material
printed in the English language, which Fuji shall be granted the rights to freely use for the
marketing and after-sales services of the Products in the Territory, including but not limited to
translation right of brochures, instructional material, advertising literature. In addition,
ZONARE shall provide Fuji with materials reasonably necessary to obtain health registrations, to
the extent practicable, as well as any other documents which Fuji may reasonably require for
registration purposes, at Fuji’s request and expense, if available.

          (b) Quotations to Exporters. ZONARE shall refrain from giving quotations to exporters
for Products to be shipped to the Territory.

     8. Term And Termination

          (a) Term. This Agreement shall continue in force until December 31, 2010, unless
terminated earlier under the provisions of this Section 8. At the end of the term, this
Agreement shall automatically renew for subsequent one year periods provided that the parties agree
on minimum purchases per Exhibit C for each subsequent period.

          (b) Termination for Cause. If either party defaults in the performance of any
provision of this Agreement, then the non-defaulting party may give written notice to the
defaulting party that if the default is not cured within [*] the Agreement will be terminated. If
the non-defaulting party gives such notice and the default is not cured during the [*] period, then
the Agreement shall automatically terminate at the end of that period.

          (c) Termination for Insolvency. This Agreement shall terminate automatically, with no
action required to be taken by or on behalf of either party, (i) upon the institution by or against
the other party of insolvency, receivership or bankruptcy proceedings, appointment of an
administrator or any other proceedings for the settlement of its debts, (ii) upon the other party’s
making an assignment for the benefit of creditors, or (iii) upon the other party’s dissolution or
ceasing to do business.

          (d) Termination for Fuji Disqualification. ZONARE may terminate this Agreement
immediately by providing written notice to Fuji if Fuji becomes legally disqualified for any reason
from importing or distributing the Products in the Territory; or if Fuji loses any license or
authorization that is required under the laws of the Territory for the importation, promotion or
sale of the Products. If (i) Fuji or any of its directors, officers or significant consultants
shall be indicted for a criminal offense in connection with the dealing of the Products, (ii) a
civil lawsuit shall be commenced against Fuji or any of its directors, officers or significant
consultants alleging fraud or any crime involving moral turpitude in connection with the dealing of
the Products, or (iii) Fuji or any of its directors, officers or significant consultants shall
violate the U.S. Foreign Corrupt Practices Act in connection with the dealing of the Products, then
ZONARE shall, at its option, have the right to immediately terminate this Agreement upon giving
written notice to Fuji.

8

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

          (e) Effect of Termination.

(i) Termination shall not relieve either party of obligations incurred before the termination, and
the rights of each party against the other which may have accrued up to the date of such
termination or expiration shall remain in force. All payments outstanding shall become immediately
due upon any termination of this Agreement. Fuji shall be released from the Minimum Purchase
Commitment upon the termination of this Agreement; provided that in case such termination is
attributable to Fuji, Fuji shall be subject to the Minimum Purchase Commitment only for the
then-current calendar year.

(ii) Effective upon the termination of this Agreement, Fuji shall cease to use all Trademarks of
ZONARE and shall cease to engage in any act or omission that would indicate or suggest a
relationship with ZONARE.

(iii) Effective upon the termination of this Agreement and upon request by ZONARE, Fuji shall, at
ZONARE’s expense, to assist ZONARE to transfer to ZONARE or its designee any Product registrations,
licenses, permits, consents or other approvals by government agencies obtained by Fuji in order for
ZONARE or its designee to import, distribute or sell the Products in the Territory.

          (f) Limitation on Liability. It is expressly understood and agreed that the rights of
termination and non-renewal set forth in this Agreement are absolute, and that the parties have
considered the possibility of such termination or non-renewal and the possibility of loss and
damage resulting therefrom, in making expenditures pursuant to the performance of this Agreement.
It is the express intent and agreement of the parties that neither shall be liable to the other for
damages or otherwise by reason of the termination of this Agreement as provided in this Section
8, provided that such termination shall not operate to discharge or release either party of
obligations assumed by it prior to such termination. The parties expressly agree that the notice
periods in this Agreement are reasonable under the contemplated circumstances and that the parties
have considered the possibility of the making of expenditures by one or both of the parties hereto
in preparing for and in the actual performance of this Agreement, and have considered the
possibility of loss and damage resulting from the termination hereof. In the event of termination
by either party in accordance with the provisions of this Agreement, neither party shall be liable
to the other, because of such termination, for compensation, reimbursement or damages on account of
the loss of prospective profits or anticipated sales or on account of expenditures, inventory,
investments, leases or commitments in connection with the business or goodwill of ZONARE or Fuji.

     9. Limitation On Liability

          (a) Personal Injury. ZONARE shall defend or settle third party claims brought against
Fuji, its distributors and customers alleging personal injury liability that is caused by defects
in Products supplied to Fuji by ZONARE, and shall indemnify Fuji, its distributors and customers
from any expenses, costs and damages suffered by them and damages finally awarded to such third
party in connection therewith, provided that (i) such defect existed at the time the Product was
shipped by ZONARE, (ii) no modifications in design have been made by or with the approval of Fuji
or the end user, (iii) the Product has not been subject to misuse, negligence or accident, (iv) the
Product has not had its serial or lot number altered, effaced or removed, (v) the Product has been
used in accordance with its Instructions for Use, and (vi) Fuji promptly notifies ZONARE of such
claim, gives ZONARE sole control over the defense or settlement of such claims, and provides ZONARE
with sufficient information and reasonable assistance in the defense of such claim.

9

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

          (b) Limitation on Liability. IN NO EVENT SHALL ZONARE BE LIABLE FOR COSTS OF
PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES, OR FOR ANY LOST PROFITS OR LOSS OF ANTICIPATED
PROFITS. IN NO EVENT SHALL ZONARE BE LIABLE TO FUJI OR ANY OTHER ENTITY FOR ANY SPECIAL,
CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR INDIRECT DAMAGES, HOWEVER CAUSED AND ON ANY THEORY OF
LIABILITY, ARISING OUT OF THIS AGREEMENT. THESE LIMITATIONS SHALL APPLY NOTWITHSTANDING ANY
FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. HOWEVER, THIS SECTION 9 WILL NOT LIMIT
ZONARE’S LIABILITY FOR CONTRIBUTION OR INDEMNITY, IF ANY, WITH RESPECT TO THIRD PARTY CLAIMS FOR
PERSONAL INJURY, DEATH, PHYSICAL DAMAGE TO PROPERTY OR INFRINGEMENT OF INTELLECTUAL PROPERTY.

     10. Property Rights And Confidentiality

          (a) Property Rights. Fuji agrees that ZONARE owns all right, title, and interest in
the product lines that include the Products and in all of ZONARE’s patents, trademarks, inventions,
copyrights, know-how, trade secrets and other intellectual property rights relating to the design,
manufacture, operation or service of the Products. The use by Fuji of any of these property rights
is authorized only for the purposes herein set forth, and upon termination of this Agreement for
any reason such authorization shall cease.

          (b) No License Right. The Products are offered for sale and are sold by ZONARE
subject in every case to the condition that such sale does not convey any license or sub-license,
expressly or by implication, with respect to the Products, or any of them, including without
limitation to manufacture, duplicate or otherwise copy or reproduce any of the Products.

          (c) Confidentiality. Each party acknowledges that by reason of its relationship to
the other party hereunder it will have access to certain information and materials concerning the
other party’s business, plans, customers, technology and products that are confidential and of
substantial value to the other party, which value would be impaired if such information were
disclosed to third parties. Each party agrees that it will not use in any way for its own account
or the account of any third party, nor disclose to any third party, any such confidential
information revealed to it by the other party. The receiving party shall take every reasonable
precaution to protect the confidentiality of such information. Upon request by the receiving
party, the disclosing party shall advise whether or not it considers any particular information or
materials to be confidential; provided, that information shall not be deemed confidential if it (i)
is known to the receiving party, as evidenced by the receiving party’s written records, before
receipt thereof under this Agreement; (ii) is disclosed to the receiving party by a third person
who is under no obligation of confidentiality to the disclosing party with respect to such
information and who otherwise has a right to make such disclosure; (iii) is or becomes generally
known in the trade through no fault of the receiving party; or (iv) is independently developed by
the receiving party, as evidenced by the receiving party’s written records, without access to such
information. In the event of termination of this Agreement, there shall be no use or disclosure by
the receiving party of any confidential information of the disclosing party.

	 	 	11.Patent, Copyright And Trademark Indemnity

10

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

          (a) Indemnification by ZONARE. ZONARE shall defend, or at its option shall settle,
any claim, suit or proceeding brought against Fuji, its distributors or customers on the issue of
infringement of any U.S. patent and its equivalent patent in the Territory existing as of the
Effective Date, copyright or trademark by the Products sold hereunder or the use thereof, subject
to the limitations hereinafter set forth. ZONARE shall have sole control of any such action or
settlement negotiations, and ZONARE agrees to pay any final judgment entered against Fuji, its
distributors or its customers on such issue in any such suit or proceeding defended by ZONARE.
Fuji agrees that ZONARE at its sole option shall be relieved of the foregoing obligations unless
Fuji, its distributors or its customers notifies ZONARE promptly in writing of such claim, suit or
proceeding and gives ZONARE authority to proceed as contemplated herein and, at ZONARE’s expense,
gives ZONARE sufficient information and reasonable assistance to settle and/or defend any such
claim suit or proceeding. If the Products, or any part thereof, are, or in the opinion of ZONARE
may become, the subject of any claim, suit or proceeding for infringement of any patent, copyright
or trademark, or if it is adjudicatively determined that the Products, or any part thereof,
infringe any patent, copyright or trademark, or if the sale or use of the Products, or any part
thereof, is, as a result, enjoined, then ZONARE may, at its option and expense either: (i) procure
for Fuji, its distributors and its customers the right under such patent, copyright or trademark to
sell or use, as appropriate, the Products or such part thereof; or (ii) replace the Products, or
part thereof, with other suitable Products or parts; or (iii) suitably modify the Products, or part
thereof; or (iv) if the use of the Products, or part thereof, is prevented by injunction, remove
the Products, or part thereof, and refund the aggregate payments paid therefore by Fuji, less a
reasonable sum for use and damage. ZONARE shall not be liable for any costs or expenses incurred
without its prior written authorization, which authorization shall not be unreasonably withheld or
delayed.

          (b) Limitation. Notwithstanding the provisions of Subsection 11(a) above,
ZONARE assumes no liability for (i) infringements covering completed equipment or any assembly,
combination, method or process in which any of the Products may be used but not covering the
Products when used alone; (ii) trademark infringements involving any marking or branding not
applied by ZONARE or involving any marking or branding applied at the request of Fuji; or
(iii) infringements involving the modification or servicing of the Products, or any part thereof,
unless such modification or servicing was done by ZONARE or under ZONARE’s authorization.

          (c) Entire Liability. The foregoing provisions of this Section 11 state the
entire liability and obligations of ZONARE and the exclusive remedy of Fuji, its distributors and
customers, with respect to any alleged infringement of patents, copyrights, trademarks or other
intellectual property rights by the Products or any part thereof.

     11A. Indemnification by Fuji

     Fuji shall defend or settle third party claims brought against ZONARE resulting from Fuji’s
performance or omission of performance in reselling the Products, and shall indemnify ZONARE from
any expenses, costs and damages suffered by ZONARE and damages finally awarded to such third party
in connection therewith. The foregoing indemnity shall not extend to claims covered by Section
9(a) above. If Fuji makes a warranty, or guarantee about the safety, operation and performance of
the Products beyond the warranty or guarantee granted by ZONARE to Fuji, Fuji will be responsible
for such warranty or guaranty.

11

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

     12. General Provisions

          (a) Governing Law. This Agreement, and ZONARE’s and Fuji’s relationship, and any
matter arising in respect or in connection therewith, shall be solely and exclusively governed by
and construed under the laws of the State of California, U.S.A without giving effect to the
conflict of laws provisions thereof. The parties expressly disclaim the application of the United
Nations Convention on the International Sale of Goods to this Agreement.

          (b) Arbitration. The parties hereto agree that any dispute or controversy arising out
of, in relation to, or in connection with this Agreement, or the validity, enforceability,
construction, performance or breach thereof, shall be finally settled by binding arbitration in
Pleasanton, California, under the then-current International Commercial Arbitration Rules of the
American Arbitration Association by one (1) arbitrator appointed in accordance with such Rules.
The rules of discovery determined by the arbitrator shall apply thereto. The parties agree that
judgment upon the decision and/or award rendered by the decision may be entered in any court of
competent jurisdiction. The costs of the arbitration, including administrative fees and fees of the
arbitrator, shall be shared equally by the parties, unless otherwise determined by the arbitrator.
Each party shall bear the cost of its own attorneys’ fees and expert fees. In addition to the right
under the Rules to petition the court for provisional relief, the parties agree that any party may
also petition the court for injunctive relief where either party alleges or claims a violation of
confidentiality obligations under Section 10 of this Agreement.

          (c) Entire Agreement; Amendments. This Agreement and the Exhibits attached hereto
sets forth the entire agreement and understanding of the parties relating to the subject matter
herein and merges all prior discussions between them. No representations, inducements, promises or
agreements, whether oral or otherwise, between the parties not contained herein or incorporated
herein by reference shall be of any force or effect. Except as set forth herein, no modification
of or amendment to this Agreement, nor any waiver of any rights under this Agreement, nor any
agreement or understanding extending this Agreement or varying its terms (including any
inconsistent terms in any purchase order, acknowledgement or similar form) shall be effective
unless in writing signed by both parties to this Agreement.

          (d) Notices. Any notice required or permitted by this Agreement shall be in writing
and shall be sent by prepaid registered or certified mail, return receipt requested, addressed to
the other party at the address shown at the beginning of this Agreement or at such other address
for which such party gives notice hereunder. Such notice shall be deemed to have been given five
(5) days after deposit in the first class mail.

          (e) Force Majeure and Inability to Deliver.

(i) Nonperformance of either party shall be excused to the extent that performance is rendered
impossible due to industrial conflicts, mobilization, requisition, embargo, currency restriction,
insurrection, general shortage of transport, material or power supply, fire, explosion, terrorism,
stroke of lightning, force majeure and similar casualties or other events beyond Fuji’s or ZONARE’s
control, as well as default in deliveries from subcontractors due to such circumstances as defined
in this clause.

12

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

(ii) If the performance of this Agreement by either party is made commercially impracticable (i) by
the occurrence of an economic contingency the non-occurrence of which was a basic assumption on
which this Agreement was made or (ii) by compliance in good faith with any applicable foreign or
domestic governmental law, regulation, or order, then this Agreement shall terminate immediately.
For purposes of this Agreement, currency devaluation, currency restrictions, currency and exchange
controls, and other monetary controls, restrictions, and restraints shall not be considered to
render the performance of this Agreement by Fuji commercially impracticable, or otherwise be
considered force majeure with respect to Fuji.

          (f) Nonassignability and Binding Effect. Neither party may transfer or assign any of
its rights and obligations under this Agreement without the prior written consent of the other
party. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of
the parties hereto and their successors and assigns.

          (g) Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original and all of which together shall constitute one instrument.

          (h) Severability. If one or more of the provisions in this Agreement are deemed void
by law, then the remaining provisions will continue in full force and effect.

          (i) No Waiver of Rights. No failure or delay by either party in exercising any right
or remedy under this Agreement shall be construed as a waiver of such right or remedy, nor shall
any single or partial exercise of any right or remedy preclude any further or other exercise of
such right or remedy. All rights and remedies under this Agreement are cumulative and shall not be
deemed exclusive of any other rights or remedies provided by law.

          (j) Captions. Captions of the sections and subsections of this Agreement are for
reference purposes only and do not constitute terms or conditions of this Agreement and shall not
limit or affect the meaning or construction of the terms and conditions hereof.

          (k) Word Meanings. Words such as herein, hereinafter, hereof and hereunder refer to
this Agreement as a whole and not merely to a section or paragraph in which such words appear,
unless the context otherwise requires. The singular shall include the plural, and each masculine,
feminine and neuter reference shall include and refer also to the others, unless the context
otherwise requires.

          (l) Rules of Construction. The parties agree that they have participated equally in
the formation of this Agreement and that the language and terms of this Agreement shall not be
preemptively construed against either of them.

          (m) Survival of Certain Terms. The provisions of Sections 3(f), 3(i), 4(a), 5,
6(f), 6(g), 6(j), 6(k), 8(e), 8(f), 9, 10, 11 and 12  shall survive the termination of this
Agreement for any reason. All other rights and obligations of the parties shall cease upon
termination of this Agreement.

13

 

     In Witness Whereof, the parties have executed this Agreement as of the date written
above.

	 	 	 	 	 	 	 	 	 	 	 
	ZONARE MEDICAL SYSTEMS, INC.	 	 	 	FUJI PHOTO FILM CO., LTD.	 	 

 

 

	 	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Donald Southard	 	 	 	By:	 	/s/ [*]	 	 
	 

	 	 

	 	 	 	 	 	 

	 	 
	Title:

	 	President and CEO
	 	 	 	Title:
	 	[*]	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Name:

	 	Donald Southard
	 	 	 	Name:
	 	[*]	 	 

14

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

Exhibit A

Product Description And Territory

Product:

[*]

[*]

[*]

[*]

[*]

[*]

Territory:

        Japan

15

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

Exhibit B

Pricing

	 	 	 	 	 
	 	 	Fuji Net Price [*]
	[*]
	 	 	[*]  	 
	[*]
	 	 	[*]  
	[*]
	 	 	[*]  	 
	[*]
	 	 	[*]  	 
	[*]
	 	 	[*]  	 
	[*]
	 	 	[*]  	 

16

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

Exhibit C

Minimum Purchases, Demo Products, and Inventory

Minimum Purchases:

During the term of this Agreement, Fuji shall purchase at least Products, including Demo Products
as indicated below (with each Product consisting of a [*]), during each of the Years Ended December
31:

2006 –  [*]

2007 –  [*]

2008 –  [*]

2009 –  [*]

2010 –  [*]

Minimum
purchases for periods subsequent to December 31, 2010 are
[*] prior to
each period end.

Demo Products:

Within [*] after receipt of regulatory approval by the Japanese authorities to begin marketing of
the Products Fuji shall purchase the following Product quantities:

[*] - [*]

[*] - [*]

[*] - [*]

[*] - [*]

Service Spares and Replacement Parts:

During the term of this Agreement, Fuji shall purchase and maintain an inventory of service spares
and replacement parts as follows:

	 	 	 	 	 
	Installed	 	Service	 	Replacement
	Base	 	Spares Kits	 	Parts Kits
	[*]

	 	[*]
	 	[*]
	[*]
	 	[*]
	 	[*]
	[*]
	 	[*]
	 	[*]
	[*]
	 	[*]
	 	[*]
	[*]
	 	[*]
	 	[*]
	[*]
	 	[*]
	 	[*]

The Service Spare Kit shall consist of one (1) of each of the Products in Exhibit A. The
Replacement Parts Kit will be defined as a part of the Service Procedures and Standards.

17

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the
Securities and Exchange Commission. Confidential treatment has been requested with respect
to the omitted portions.

 

January 30, 2007

FUJIFILM Corporation

26-30, Nishiazabu 2-chome, Minato-ku

Tokyo 106-8620

Japan

Attn:           [*]

Re: OEM Purchase Agreement

Dear Mr. Kato:

Reference is made to the OEM PURCHASE AGREEMENT as of March 15, 2006 between ZONARE Medical
Systems, Inc (“ZONARE”) and Fuji Photo Film Co., Ltd. (“Agreement”), which has been duly
transferred to FUJIFILM Corporation (“FUJIFILM”) as of October 1, 2006 as result of a
Corporate-Split.

This is to confirm and acknowledge the following:

	1.	 	ZONARE and FUJIFILM agree that the first sentence of Article 11(a) of the Agreement
“Indemnification by ZONARE” shall be hereby amended and replaced in its entirety to
read as follows:

     “ZONARE shall defend, or at its option shall settle, any claim, suit or proceeding
brought against Fuji, its distributors or customers on the issue of infringement of any
patent in the United States or Territory, copyright or trademark by the Products sold
hereunder or the use thereof, subject to the limitations hereinafter set forth.”

	2.	 	ZONARE and FUJIFILM agree that Exhibit A of the Agreement shall be hereby amended and
replaced in its entirety to read as attached hereto.
	 
	3.	 	Except as modified herein, the terms of the Agreement shall remain in full force and effect
between ZONARE and FUJIFILM.
	 
	4.	 	This letter agreement shall become effective on December 1, 2006.

Please confirm your acceptance of the terms of this letter agreement by your countersignature in
the space provided below.

Very truly yours,

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

ZONARE MEDICAL SYSTEMS, INC.

/s/ Donald Southard                                                            

Donald Southard

President and CEO

Agreed and Accepted:

FUJIFILM Corporation

/s/ [*]                                        

[*]

Date:                                        

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

Exhibit A (Revised as of December 1, 2006)

Product Description And Territory

Product:

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

Territory:

Japan

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

2ND AMENDMENT TO OEM PURCHASING AGREEMENT

ZONARE MEDICAL SYSTEMS, INC., a Delaware corporation with principal offices at 1061 Terra Bella
Avenue, Mountain View, California 94043, U.S.A.

and

FUJIFILM Corporation, a Japanese corporation with principal offices at 26-30, Nishazabu 2-Chome
Minato-Ku, Tokyo 106-8620, Japan

hereby agree to replace Exhibit A of OEM PURCHASING AGREEMENT made and entered into on March 15,
2007 and subsequently amended on January 30, 2007 with the revised Exhibit A as attached hereto.

Except as expressly amended herein, all the terms and conditions of the aforesaid OEM PURCHASING
AGREEMENT shall remain in full force and effect.

This Amendment shall become effective on May 1, 2007.

	 	 	 	 	 	 	 	 	 	 	 
	ZONARE MEDICAL SYSTEMS, INC.	 	 	 	FUJIFILM CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Donald Southard
 

	 	 
	 	By:
	 	/s/ [*]
 

	 	 
	 

	 	          Donald Southard
	 	 	 	[*]	 	 	 	 
	 

	 	          President and CEO	 	 	 	 	 	 	 	 

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

Exhibit A Revised as of May 1, 2007

Product Description and Territory

Product:

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

Territory:

Japan

 

			
	[*]	 	Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.exv10w14

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

EXHIBIT 10.14

SETTLEMENT AND NONEXCLUSIVE LICENSE AGREEMENT

     This Settlement and Nonexclusive License Agreement (“Agreement”) is made by and between
SonoSite, Inc. (“SonoSite”), and Zonare Medical Systems, Inc. (“Zonare”).

Recitals

WHEREAS, SonoSite and Zonare represent that they own patents and patent applications relating to
ultrasound systems; and

WHEREAS, SonoSite and Zonare are engaged in litigation regarding SonoSite’s U.S. Patent No.
5,722,412
(the “ ‘412 Patent”) and Zonare’s U.S. Patent No. 6,980,419 (the “ ‘419 Patent”); and

WHEREAS, SonoSite and Zonare each deny the allegations made by the other in the litigation, and
desire to resolve the litigation in accordance with the terms hereof; and

WHEREAS, in connection with the Parties’ resolution of the litigation, Zonare and SonoSite desire a
nonexclusive license under the ‘412 Patent and ‘419 Patent, respectively, together with a covenant
by the granting Party not to assert patent claims against the licensee Party for a limited period
of time as specified herein.

NOW, THEREFORE, in consideration of the mutual covenants and representations contained herein, and
in order to resolve the litigation and to forestall future disputes between the Parties, Zonare and
SonoSite hereby agree as follows:

Article 1 Definitions

	1.01	 	The “Action” means the action entitled SonoSite, Inc. v. Zonare Medical Systems, Inc.
(and related counterclaims), Case No. SACV 07-222AG.

	1.02	 	“Affiliate” means an entity over which a Party exercises Control. An entity will be an
Affiliate only for as long as it satisfies the definition set forth herein. “Affiliate”
includes current and future Affiliates (unless otherwise expressly set forth herein).
	 
	1.03	 	“Change of Control” of an entity means the occurrence of any of the following events:

(a) a transaction or series of transactions whereby any “person” or related “group” of
“persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act)
directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under
the Exchange Act) of securities of the entity possessing 50% or more of the total combined
voting power of the entity’s securities outstanding immediately after such acquisition; or

(b) the consummation by the entity of (i) a merger, consolidation, reorganization
or business combination or (ii) a sale or other disposition of all or substantially all
of the entity’s assets, in each case, other than a transaction in which the holders of
the equity interests in the entity immediately prior to the transaction
will, immediately after such transaction, have 50% or more of the voting power of the equity
interests in the entity that survives the merger, consolidation, reorganization or business
combination or acquire all or

-1 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

	 	 	substantially all of the entity’s assets or otherwise succeed to the business of the entity,
which voting securities are to be held by such holders immediately following such
transaction in substantially the same proportion among themselves as such holders’ ownership
of the equity interests in the entity immediately before such transaction.
	 
	 	 	For purposes of this section, the sale of securities to the public pursuant to an initial
public offering shall not be considered a “change of control.”
	 
	1.04	 	“Control” means possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of an entity, such as by (a) owning more than 50% of
the outstanding stock, (b) controlling more than 50% of the voting rights to elect directors,
or (c) otherwise having the legal right to direct the management and operations of the entity.
	 
	1.05	 	“Effective Date” means the date of signature of the last Party to sign this Agreement.
	 
	1.06	 	“Patents” means all valid, enforceable, and unexpired patents and patent applications
throughout the world filed as of the Effective Date, including all reissues, reexaminations,
extensions, continuations, continuations-in-part, continuing prosecution applications, and
divisionals of such patents and patent applications, and any foreign counterparts to any of
the foregoing, including without limitation utility models or provisional applications but
expressly excluding design patents.
	 
	1.07	 	“SonoSite Patents” means [*].
	 
	1.08	 	“Zonare Patents” means [*].
	 
	1.09	 	“Licensed Zonare Products” means [*].
	 
	1.10	 	“Licensed SonoSite Products” means [*].
	 
	1.11	 	“Party” means SonoSite or Zonare, and “Parties” means SonoSite and Zonare.

Article 2 License Grant, Covenant, and Release

	2.01	 	License Grant by SonoSite. Subject to the terms of this Agreement, SonoSite on
behalf of itself and its Affiliates, and their successors and permitted assigns, hereby grants
to Zonare and its Affiliates, and their end users, customers, distributors, resellers and
OEMs, a worldwide, non-exclusive, non-transferable (except as set forth expressly herein),
fully paid-up, irrevocable (except as set forth expressly herein), perpetual license under the
‘412 Patent (including any foreign counterparts thereto) to make, have made, use, license,
sell, have sold, offer for sale, import, distribute directly and indirectly through multiple
tiers of distribution, or otherwise dispose of, Licensed Zonare Products.
	 
	2.02	 	License Grant by Zonare. Subject to the terms of this Agreement, Zonare on behalf of
itself and its Affiliates, and their successors and permitted assigns, hereby grants to
SonoSite and its Affiliates, and their end users, customers, distributors, resellers and OEMs,
a worldwide, non-exclusive, non-transferable (except as set forth expressly herein), fully
paid-up, irrevocable (except as set forth expressly herein), perpetual license under the ‘419
Patent (including any foreign counterparts thereto) to make, have made, use, license, sell,
have sold, offer for sale, import, distribute directly and indirectly through multiple tiers
of distribution, or otherwise dispose of, Licensed SonoSite Products.

-2 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

	2.03	 	Covenant Not To Sue. SonoSite and Zonare each covenant not to sue the other, or
officers, agents or Affiliates of the other Party, or the other Party’s permitted successors
and assigns (except with respect to products or services of such permitted successors and
assigns which are not obtained from such other Party pursuant to such succession or
assignment), or the other Party’s end users, customers, distributors, resellers and OEMs (to
the extent that a claim against such other Party’s end users, customers, distributors,
resellers
or OEMs is based on use of the other Party’s products or services), on any claim for
infringement of any SonoSite Patents or Zonare Patents, respectively, or on any claim for
invalidity of any Zonare Patents or SonoSite Patents, respectively, for a [*] period
commencing on the Effective Date of this Agreement and terminating on the [*] date
thereafter. Neither Party has the right to initiate a suit involving such claim for
infringement or invalidity [* ].
	 
	2.04	 	Release by SonoSite. Subject to the payments made by Zonare to SonoSite provided for
under Section 3.01, SonoSite on behalf of itself and its Affiliates, and their permitted
successors and assigns, irrevocably and perpetually releases and discharges Zonare and its
Affiliates existing as of the Effective Date (“Existing Affiliates” of Zonare), and their
respective employees, attorneys, officers, directors, shareholders, representatives, agents,
customers, distributors, suppliers, purchasers, resellers, OEMs and end users anywhere in the
world from any liability for infringement of any claim of the ‘412 Patent based on Zonare’s or
its Existing Affiliate’s manufacture, having manufactured, use, sale, having sold, offer for
sale, or import of products or services prior to the Effective Date. For the avoidance of
doubt, this release does not extend to (a) any acts of any of the foregoing named entities
that occur after the Effective Date, or (b) any entity which is not an Existing Affiliate but
becomes Zonare’s Affiliate after the Effective Date.
	 
	2.05	 	Release by Zonare. Zonare on behalf of itself and its Affiliates, and their
permitted successors and assigns, irrevocably and perpetually releases and discharges SonoSite
and its Affiliates existing as of the Effective Date (“Existing Affiliates” of SonoSite), and
their respective employees, attorneys, officers, directors, shareholders, representatives,
agents, customers, distributors, suppliers, purchasers, resellers, OEMs and end users anywhere
in the world from any liability for infringement of any claim of the ‘419 Patent based on
SonoSite’s or its Existing Affiliate’s manufacture, having manufactured, use, sale, having
sold, offer for sale, or import of products or services prior to the Effective Date. For the
avoidance of doubt, this release does not extend to (a) any acts of any of the foregoing named
entities that occur after the Effective Date, or (b) any entity which is not an Existing
Affiliate but becomes SonoSite’s Affiliate after the Effective Date.

Article 3 Consideration

	3.01	 	Lump Sum Payment. As partial consideration for the licenses, covenants not to sue,
releases and rights granted to Zonare as of the Effective Date, Zonare will pay SonoSite a
lump sum payment of three million two hundred fifty thousand dollars ($3,250,000), which shall
be payable in two installments, as follows: Zonare will pay SonoSite two million dollars (US
$2,000,000) within ten (10) business days of the Effective Date and Zonare will pay SonoSite
one million two hundred fifty thousand dollars ($1,250,000) on the first anniversary of the
Effective Date. These two installment payments shall constitute the sole payment obligations
of Zonare pursuant to this Agreement. Because Zonare’s payment of the entire $3,250,000
amount specified above is a necessary condition to SonoSite’s release set forth in Section
2.04, Zonare’s obligation to make these two installment payments shall be irrevocable,
regardless of any patent office actions or court rulings regarding the ‘412 patent or any of
its foreign counterparts.
	 
	3.02	 	Dismissal. Within five (5) days of Zonare’s two million dollar installment payment
pursuant to Section 3.01 hereof, and as partial consideration for the licenses, covenants not
to sue, releases and rights granted to each Party by the other Party herein to resolve and
settle the Action and to forestall future disputes between the Parties, the Parties shall
cause to be filed a dismissal with prejudice of the Action, each Party to bear its own costs
and fees of said dismissal.

-3 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

Article 4 Term and Termination

	4.01	 	Term. This Agreement shall be effective on the Effective Date and (a) with respect
to the licenses granted under the ‘412 Patent and the ‘419 Patent, shall expire upon
expiration of the last-to-expire of such Patents which are the subject of such licenses,
unless earlier terminated pursuant to the terms hereof; and (b) with respect to the covenants
not to sue, shall expire on [*] of the Effective Date, unless earlier terminated pursuant to
the terms hereof.
	 
	4.02	 	Termination of Zonare Licenses and SonoSite Covenants Upon Payment Default by Zonare.
The licenses granted to Zonare and the covenants made by SonoSite under this Agreement shall
automatically terminate should Zonare fail to make either of the installment payments set
forth in Section 3.01, if such failure is not cured within fifteen (15) days of receipt by
Zonare of written notice delivered by SonoSite regarding Zonare’s failure to make such
payment(s).
	 
	4.03	 	Termination Upon Patent Challenge. If, after the Effective Date and dismissal of the
Action, a licensee Party challenges the validity, enforceability, or infringement of any of
licensor Party’s Patents for which a non-exclusive license has been granted to the licensee
Party, including, without limitation, in an interference or opposition proceeding, (for the
sake of clarity, if Zonare makes such challenge as a licensee Party, the licensor Party’s
Patents would be the ‘412 Patent and any foreign counterparts thereto, and if SonoSite makes
such challenge as a licensee Party, the licensor Party’s Patents would be the ‘419 Patent and
any foreign counterparts thereto), or if such licensee Party supports or directly or
indirectly assists any third party in challenging the validity, enforceability, or
infringement of such licensor Party’s Patents, including, without limitation, in an
interference or opposition proceeding, then the licenses and covenant not to sue granted to
such challenging licensee Party herein may be terminated immediately upon written notice by
the licensor Party. Provided, however, if any subpoena or court order shall require the
disclosure of any document, information and/or work product relating to the validity,
enforceability or infringement of such licensor Party’s Patents (for example, by way of
document production and/or testimony), disclosure pursuant to such subpoena or court order
shall not constitute assistance under this provision so long as the Party required to make
such disclosure shall give the other Party and its attorneys reasonable prior written notice
so that the other Party has an opportunity to intervene and oppose the disclosure of such
documents, information and/or work product.
	 
	4.04	 	Termination Upon Change of Control and Successor Fails to Meet Terms of the
Agreement. Should any successor of a Party provided for under Sections 6.01 and 6.02 fail
to materially meet all terms of this Agreement, then to the extent any licenses and covenant
not to sue have been granted by the other Party to such successor hereunder, such licenses and
covenant not to sue may be terminated immediately by such other Party (the granting Party) if
such failure is not cured by such successor within fifteen (15) days of delivery of written
notice of such failure by the other (granting) Party.
	 
	4.05	 	Termination for Bankruptcy. Each Party acknowledges that all rights and licenses
granted by it under or pursuant to this Agreement are, and shall otherwise be deemed to be,
for purposes of Section 365(n) of the United States Bankruptcy Code (the “Bankruptcy Code”),
licenses of rights to “intellectual property” as defined under Section 35(A) of the Bankruptcy
Code. Each Party acknowledges that if such Party, as a debtor in possession or a
trustee-in-bankruptcy in a case under the Bankruptcy Code, rejects this Agreement, the other
Party may elect to retain its rights under this Agreement as provided in Section 365(n) of the
Bankruptcy Code. Subject to the foregoing, in the event a Party files a voluntary petition
for bankruptcy, has an involuntary petition for bankruptcy filed against it which is not
dismissed within sixty (60) days, makes an assignment for the benefit of its creditors, or has
a receiver appointed for all or a portion of its property, the Party not experiencing such
event shall have the right to terminate this Agreement immediately upon written notice to the
Party experiencing such event (the “Insolvent Party”).
	 
	4.06	 	Termination for Material Breach. Except as otherwise expressly set forth herein, in
the event a Party breaches any material obligation under this Agreement or any provision
hereof and fails to cure such

-4 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

	 	 	breach within thirty (30) days after receipt of written notice
thereof from the non-breaching Party, the non-breaching Party shall have the right to
immediately terminate the licenses and covenant not to sue granted to the breaching Party upon
written notice to the breaching Party.
	 
	4.07	 	Other Available Rights and Remedies. With respect to any termination right set forth
in this Article 4, the Party having such right to terminate also shall retain, and shall have
the right to seek, all rights and remedies available at law or in equity, including, but not
limited to, contract damage remedies.

Article 5 Representations

	5.01	 	Right to Enter Into Agreement. SonoSite and Zonare represent and warrant that each
respective Party has the right and authority to enter into this Agreement.

5.02   Limitations. Nothing in this Agreement shall be construed as:

	 	(a)	 	a warranty or representation by SonoSite or Zonare as to the validity,
enforceability or scope of any SonoSite Patent or Zonare Patent, respectively; or
	 
	 	(b)	 	a warranty or representation that anything made, used, sold, offered for sale,
imported, or otherwise disposed of pursuant to this Agreement is or will be free from
infringement of patents or other intangible rights of third parties; or
	 
	 	(c)	 	a requirement that SonoSite or Zonare shall file any patent application, secure
any patent, or maintain any patent in force; or
	 
	 	(d)	 	an obligation that SonoSite or Zonare bring or prosecute actions or suits
against third parties for infringement of the SonoSite Patents or Zonare Patents,
respectively; or
	 
	 	(e)	 	a grant to a licensee Party, by implication, estoppel or otherwise, of any
license, right or privilege under any Patents of the licensor Party, except as
expressly granted herein; or
	 
	 	(f)	 	an obligation to furnish any manufacturing or technical information or
know-how.

Article 6 Assignment

	6.01	 	Assignment by Zonare. This Agreement has been entered into by SonoSite in reliance
upon the particular characteristics of Zonare and is personal to Zonare. Neither this
Agreement, nor any rights or obligations hereunder, may be assigned, pledged or encumbered by
Zonare without the express prior written approval of SonoSite, which shall not be unreasonably
withheld or delayed by SonoSite. Notwithstanding the foregoing, Zonare may assign this
Agreement without SonoSite’s consent to a successor-in-interest pursuant to a Change of
Control if such successor-in-interest agrees to be bound by this Agreement in a writing
delivered to SonoSite at the time of or reasonably promptly after such Change of Control;
provided, however, that the rights, licenses, covenants and obligations set forth in this
Agreement which inure to the benefit of such successor-in-interest shall extend only to the
Licensed Zonare Products. Should any successor fail to materially meet all terms of this
Agreement, SonoSite may immediately terminate the licenses and covenant not to sue granted to
such successor as provided for in Section 4.04.
	 
	6.02	 	Assignment by SonoSite. This Agreement has been entered into by Zonare in reliance
upon the particular characteristics of SonoSite and is personal to SonoSite. Neither this
Agreement, nor any rights or obligations hereunder, may be assigned, pledged or encumbered by
SonoSite without the express prior written approval of Zonare which shall not be unreasonably
withheld or delayed by Zonare. Notwithstanding the foregoing, SonoSite may assign this
Agreement without Zonare’s consent to a successor-in-interest pursuant to a Change of Control
if such successor-in-interest agrees to be bound by

-5 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

this Agreement in a writing delivered to
Zonare at the time of or reasonably promptly after such Change of Control; provided, however,
that the rights, licenses, covenants and obligations set forth in this Agreement which inure
to the benefit of such successor-in-interest shall extend only to the Licensed Sonosite
Products. Should any successor fail to materially meet all terms of this Agreement, Zonare
may immediately terminate the licenses and covenant not to sue granted to such successor as
provided for in Section 4.04.

Article 7 Additional Provisions

	7.01	 	Confidentiality. The terms of this Agreement are confidential information of both
Parties. Neither Party shall issue any press release regarding this Agreement without the
other Party’s express prior written
consent (which consent shall not be unreasonably withheld or delayed). Nothing herein shall
prevent the Parties from acknowledging the existence of this Agreement (as distinguished
from its terms, which shall remain confidential), or from disclosing the terms of this
Agreement (including the financial terms) as required by any applicable law, regulation or
accounting rules, including without limitation any securities laws, or subject to the terms
of a protective order entered into by a court requiring strict confidentiality on an
attorneys’ eyes only basis, or pursuant to a non-disclosure agreement with a third-party
seeking or being offered a business relationship with either Party relating to the subject
matter of this Agreement. If any subpoena or court order shall require the disclosure of
the terms of this Agreement (for example, by way of document production and/or testimony), a
Party required to make such disclosure shall give the other Party and its attorneys
reasonable prior written notice so that the other Party has an opportunity to intervene and
oppose the disclosure of such terms of this Agreement. This provision shall survive
expiration or termination of this Agreement.
	 
	 	 	Each Party further agrees to maintain as confidential, under the terms of the Protective
Order entered by the court in the Action, any and all documents, information and other work
product it and/or its attorneys received from the other Party or otherwise received or
developed in connection with the Action, and except as expressly permitted herein, SonoSite
agrees not to disclose such documents, information and work product to any third party in
support of any actual or potential claims based on ‘419 Patent and Zonare agrees not to
disclose such documents, information and work product to any third party in support of any
actual or potential claims based on the ‘412 Patent, and with respect to such actual or
potential claims based on such Patent of the other Party, each Party agrees not to
voluntarily work or cooperate with any third party in connection with any such claim(s), and
not to offer in evidence in any civil, criminal, administrative or other action or
proceeding by any third party in connection with any such claim(s), any of such documents,
information and other work product received from the other Party or otherwise received or
developed in connection with the Action and subject to such Protective Order.
Notwithstanding anything to the contrary in this Section 7.01, and except with respect to
materials and information designated by Zonare as “Confidential” or “Attorneys’ Eyes Only”
under the Protective Order in this Action, all of which shall be treated in accordance with
the terms of that Protective Order, SonoSite may disclose and use for any and all purposes
any and all documents, information and other work product it and/or its attorneys received
from the other Party or otherwise received or developed in connection with the Action which
are related to its ‘412 Patent (but are not related to the ‘419 Patent), and except with
respect to materials and information designated by SonoSite as “Confidential” or “Attorneys’
Eyes Only” under the Protective Order in this Action, all of which shall be treated in
accordance with the terms of that Protective Order, Zonare may disclose and use for any and
all purposes any and all documents, information and other work product it and/or its
attorneys received from the other Party or otherwise received or developed in connection
with the Action which are related to its ‘419 Patent (but are not related to the ‘412
Patent). Provided, however, if any subpoena or court order shall require the disclosure of
any such documents, information and/or work product received by or prepared by one Party
relating to the validity, enforceability or infringement of such other Party’s Patent (for
example, by way of document production and/or testimony) which are subject to such
Protective Order, then disclosure of such documents, information and/or work product by the
recipient or preparor Party pursuant to such subpoena or court order shall not constitute
breach under this provision so long as the recipient or preparor Party required to make such
disclosure shall give the other Party and its attorneys reasonable prior written notice so
that the

-6 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

	 	 	other Party has an opportunity to intervene and oppose the disclosure of such
documents, information and/or work product.
	 
	7.02	 	No Admission of Liability. Neither the execution of this Agreement, nor the
performance of any term hereof, shall constitute, be construed as or be deemed an admission of
any liability, infringement, wrongdoing or culpability whatsoever by any Party. The Parties
expressly acknowledge and agree that this Agreement represents a settlement of disputed rights
and claims. SonoSite and Zonare affirmatively deny the allegations of the other Party with
respect to the Action.
	 
	7.03	 	Waiver. A waiver of any breach of any provision of this Agreement shall not be
construed as a continuing waiver of other breaches of the same or other provisions of this
Agreement.
	 
	7.04	 	No Agency. Nothing in this Agreement shall be deemed to create an agency, joint
venture or partnership relation between the Parties hereto.
	 
	7.05	 	Entire Agreement. This Agreement constitutes the entire agreement and understanding
of the Parties with regard to the subject matter hereof and merges and supersedes all prior
discussions, negotiations, understandings and agreements between the Parties concerning the
subject matter hereof. Neither Party shall be bound by any definition, condition, warranty,
right, duty or covenant other than as expressly stated in this Agreement or as subsequently
set forth in a written document signed by both Parties. Each Party expressly waives any
implied right or obligation regarding the subject matter hereof.
	 
	7.06	 	Governing Law, Jurisdiction and Venue. The Parties shall make all reasonable efforts
to resolve any dispute concerning this Agreement, its construction, or its actual or alleged
breach, by good-faith, face-to-face negotiations between senior executives of each Party. If
the senior executives fail to resolve such dispute, the Parties may mutually agree to resolve
such dispute through other informal procedural means, including, but not limited to, referral
to an independent, neutral third party expert, mediation, arbitration and/or any other
procedure(s) upon which the Parties mutually agree. Each Party agrees that, prior to
resorting to litigation to resolve any dispute concerning this Agreement, it will confer in
good faith with the other Party to determine whether other procedures that are less expensive
or less time consuming can be adopted to resolve the dispute. This Agreement shall be
interpreted and construed, and the legal relations created herein shall be determined, in
accordance with the laws of the State of Washington and the United States, excluding conflicts
of laws principles that would result in the application of the laws of a different
jurisdiction. The United Nations Convention on Contracts for the International Sale of Goods
does not apply to this Agreement. To the extent permitted by law, the provisions of this
Agreement supersede any provisions of the Uniform Commercial Code and the Uniform Computer
Information Transactions Act.
	 
	7.07	 	Attorneys’ Fees. If any Party to this Agreement brings an action against the other
Party to enforce its rights under this Agreement, the prevailing Party shall be entitled to
recover its costs and expenses, including reasonable attorneys’ fees and costs incurred in
connection with such action, including any appeal of such action.
	 
	7.08	 	Amendment. This Agreement may be amended only by a written document signed by
authorized representatives of both Parties.
	 
	7.09	 	Further Acts. Each Party hereto agrees to execute, acknowledge and deliver all such
further instruments, and to do all such further acts, as may be necessary or appropriate to
carry out the intent and purposes of this Agreement.
	 
	7.10	 	Headings. The headings contained in this Agreement are for reference purposes only
and shall not affect in any way the meaning or interpretation of this Agreement.

-7 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

	7.11	 	Severability. Should any part or provision of this Agreement be held unenforceable
or in conflict with the law of any jurisdiction, the validity of the remaining parts or
provisions shall not be affected by such holding. In the event a part or provision of this
Agreement that is held unenforceable or in conflict with law affects consideration to either
Party, the Parties agree to negotiate in good faith an amendment of such part or provision in
a manner consistent with the intention of the Parties as expressed in this Agreement.
	 
	7.12	 	Notices. Any and all notices or other communications required or permitted by this
Agreement or by law to be served on or given to either Party hereto by the other Party shall
be in writing and delivered or sent to:

SonoSite:

SonoSite, Inc.

21919 30th Drive SE

Bothell, WA 98021

Attn: Kathryn Surace-Smith, General Counsel

Fax: 425 951 1201

Zonare:

Zonare Medical Systems, Inc.

420 N. Bernardo Ave

Mountain View, CA 94043-5209

Attn: Tim Marcotte

Fax: 650 230 2825

	 	 	Each Party may change its address for purposes of this Agreement by written notice to the
other Party.
	 
	 	 	All notices or other communications shall be deemed duly served and given on the date when
personally delivered or delivered by reputable courier service to the Party to whom it is
directed, when transmitted electronically by facsimile (subject to receipt of a successful
transmission report), or within five (5) days of deposit in the United States mail, first
class, international postage prepaid, certified and return receipt requested, and addressed
to the Party at the above address.
	 
	7.13	 	Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which together shall constitute one and
the same instrument. Execution and delivery of this Agreement may be evidenced by facsimile
transmission.

-8 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

 

 

IN WITNESS WHEREOF, the Parties have executed this Agreement on the date(s) set forth below.

	 	 	 	 	 	 	 	 	 
	SonoSite, Inc.	 	 	 	Zonare Medical Systems, Inc.
	 
	 	 	 	 	 	 	 	 
	By

	 	/s/ Kevin M. Goodwin
	 	 	 	By
	 	/s/ Donald Southard
	 

	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Title

	 	CEO
	 	 	 	Title
	 	President and Chief Executive Officer
	 
	 	 	 	 	 	 	 	 
	Date

	 	7/16/08
	 	 	 	Date
	 	July 14, 2008

-9 of 9-

 

[*] Certain information in this document has been omitted and filed separately with the Securities
and Exchange Commission. Confidential treatment has been requested with respect to the omitted
portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]